AbbVie
ABBV
#29
Rank
โ‚น47.257 T
Marketcap
โ‚น26,743
Share price
1.49%
Change (1 day)
30.65%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): โ‚น806.12 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น64.38 Billion. In 2025 the company made an earning of โ‚น638.12 Billion, an increase over its 2024 earnings that were of โ‚น359.44 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น806.12 B26.33%
2025 โ‚น638.12 B77.53%
2024 โ‚น359.44 B-40.54%
2023 โ‚น604.56 B-53.62%
2022 โ‚น1.303 T3.76%
2021 โ‚น1.256 T282.25%
2020 โ‚น328.68 B-59.67%
2019 โ‚น815.04 B62.13%
2018 โ‚น502.70 B-32.74%
2017 โ‚น747.43 B-1.99%
2016 โ‚น762.61 B18.65%
2015 โ‚น642.77 B180.5%
2014 โ‚น229.15 B-55.57%
2013 โ‚น515.76 B-6.86%
2012 โ‚น553.77 B56.05%
2011 โ‚น354.85 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น668.11 B-20.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.249 T 286.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น995.06 B 18.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น97.83 B-88.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น189.11 Billion-122.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.152 T 36.91%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.386 T 64.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น763.15 B-9.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น79.15 B-90.59%๐Ÿ‡บ๐Ÿ‡ธ USA